A Study of a New PET Scanner in People With Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.

Eligibility criteria

Qualifiers

Patients with histologically-confirmed non-small cell lung carcinoma (NSCLC) with a single or multiple lung nodules.

Patients who are undergoing a planned PET-CT scan at main campus of MSK.

Patients must be ≥ 18 years old

Patients with disease within the chest, abdomen or pelvis, who could benefit from visualizing the pharmacokinetics of radiotracer uptake within all disease sites simultaneously.

Disqualifiers

Patients who suffer from claustrophobia.

Women who are pregnant or breast-feeding.

Patients < 18 years of age

Trial design

Treatments tested in this trial

  • Biograph Vision Quadra scanner
  • PET/CT

Treatment groups

90 Participants
are divided into 1 treatment group